Author Archives for Dr. M

Dr. M’s SPA Newsletter Volume 11 Issue 25 Covid Update #37

 

What are the latest data trends with COVID and children? What vaccine related issues have arisen? We answer these questions and more!

Quick hits

1) Sequelae following a moderate to severe COVID infection continue to plague medical systems. In a new study in the British Medical Journal, we see a 14% increased risk of developing new onset clinical conditions.

“14% of adults aged ≤65 who were infected with SARS-CoV-2 (27 074 of 193 113) had at least one new type of clinical sequelae that required medical care after the acute phase of the illness, which was 4.95% higher than in the 2020 comparator group. The risk for specific new sequelae attributable to SARS-Cov-2 infection after the acute phase, including chronic respiratory failure, cardiac arrythmia, hypercoagulability, encephalopathy, peripheral neuropathy, amnesia (memory difficulty), diabetes, liver test abnormalities, myocarditis, anxiety, and fatigue, was significantly greater than in the three comparator groups (2020, 2019, and viral lower respiratory tract illness groups).” (Daugherty et. al. 2021)……….

Read More: Link

Enjoy,

Dr. M

Dr. M’s SPA Newsletter Volume 11 Issue 24

Did you ever suffer from a cold sore caused by the herpes virus? If so, this audio newsletter is for you. We go through all of the current data regarding cause and treatment.

Herpes Labialis is a common recurrent irritation for many children and parents alike. The Red Book, the bible of pediatric Infectious diseases, is the best resource for understanding Herpes viral infections. There are 8 primary herpes viruses that infect humans including: herpes simplex virus 1 (HSV1), herpes simplex virus 2 (HSV2), varicella-zoster virus, Epstein-Barr virus, cytomegalovirus, Human herpesvirus-6, Human herpesvirus-7, and Kaposi’s sarcoma herpes virus……

Read More at https://www.salisburypediatrics.com/patient-education/dr-magryta-s-newsletter/955-volume-11-letter-24

Best,

Dr. M

 

Dr. Magryta’s Newsletter Coronavirus Update #36

We must have discourse regarding experimental vaccinations to be a moral society. For this reason, I will take on this controversial topic.
Are we all ok with an emergency use authorization for the COVID19 vaccine for children under age 16 years old? That is a loaded question. In the British Medical Journal we see a piece written by Drs. Pegden, Prasad and Baral this week. They state: “For adults, the benefits of covid-19 vaccination are enormous, while for children they are relatively minor. Rare side effects from adult covid-19 vaccination are unlikely to lead to future vaccine hesitancy whose public health impact could be comparable to the benefits of the adult covid-19 vaccination program itself. But accelerated mass child vaccination under emergency use authorization—perhaps even spurred by school mandates and “vaccine passports”—presents a different balance of risks and benefits. The possibility that rare adverse events could emerge as the more durable public health legacy of an emergency use authorization for child covid-19 vaccines is much greater.” (Pegden et. al. 2021)…….

Dr. Magryta’s Newsletter 11 V22

Photograph by Chris Magryta
Genetically modified foods, glyphosate and Immunity
Disclaimer: This is an opinion piece on a controversial topic as the science is too muddy for a clear picture. There is no clear answer to this debate! I have no dog in this fight other than human health and disease avoidance. The question has to be asked and answered. However, the individuals behind the science are often full of corporate bias making the determination of truth very troublesome.
I have long worried about the transition from all natural food to the modern pesticide laden genetically modified variety. Parsing through the research on safety is immensely difficult as the variables that need to be accounted for are numerous and most of the troubling research is only translational from animal models. Most of the negative (i.e. safe) data is industry funded causing major bias points to exist. Thus, we remain in the dark as to true risk and safety.

1 2 146